Karyopharm Therapeutics Inc. SEC filings

Filings

Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.

1. ROUTINE8-KKaryopharm Therapeutics Inc.KPTI5d

   Karyopharm extends forbearance period

   • Forbearance period extended to Oct 22, 2026
   • Original end date was Oct 15, 2026
   • Forbearance Agreement dated Sep 10, 2026
2. ROUTINESCHEDULE 13G/AKaryopharm Therapeutics Inc.KPTIOct 8

   Karyopharm Therapeutics Inc. (KPTI) sees new stake

   • Acorn Bioventures, L.P. holds 1.9% of KPTI
   • Acorn Bioventures 2, L.P. holds 2.6% of KPTI
   • Anders Hove holds 4.5% of KPTI

   ACORN BIOVENTURES, L.P., filed by

3. ROUTINE4Karyopharm Therapeutics Inc.KPTIOct 2

   KPTI: Abate Kristin sold shares

   • 10/01/2026 sale of 378 shares
   • Price: $1.19 per share
   • 23,404 shares remaining

   Kristin Abate

4. ROUTINESCHEDULE 13G/AKaryopharm Therapeutics Inc.KPTISep 25

   Ownership stake disclosure by ACORN BIOVENTURES, L.P. (amended)

   ACORN BIOVENTURES, L.P., filed by

5. ROUTINESCHEDULE 13G/AKaryopharm Therapeutics Inc.KPTISep 25

   Ownership stake disclosure by ACORN BIOVENTURES, L.P. (amended)

   ACORN BIOVENTURES, L.P., filed by

6. ROUTINE8-KKaryopharm Therapeutics Inc.KPTISep 18

   Current report

7. ROUTINE8-KKaryopharm Therapeutics Inc.KPTISep 11

   Current report

8. ROUTINESCHEDULE 13GKaryopharm Therapeutics Inc.KPTISep 4

   Ownership stake disclosure by INTEGRATED CORE STRATEGIES (US) LLC

   INTEGRATED CORE STRATEGIES (US) LLC, filed by

9. ROUTINE4Karyopharm Therapeutics Inc.KPTISep 2

   Kristin Abate, insider filing for KPTI

   Kristin Abate, reporting

10. ROUTINE8-KKaryopharm Therapeutics Inc.KPTIAug 31

    Current report

11. ROUTINESCHEDULE 13G/AKaryopharm Therapeutics Inc.KPTIAug 14

    2 13G filings

    Ownership stake disclosure by RA CAPITAL MANAGEMENT, L.P. (amended)

    Show all 2

    • SCHEDULE 13G/AOwnership stake disclosure (amended)Aug 14
    • SCHEDULE 13G/AOwnership stake disclosure (amended)Aug 14

    RA CAPITAL MANAGEMENT, L.P., filed by

12. NOTABLE10-QKaryopharm Therapeutics Inc.KPTIAug 13

    Quarterly report

13. ROUTINE8-KKaryopharm Therapeutics Inc.KPTIAug 13

    Current report

14. ROUTINESCHEDULE 13G/AKaryopharm Therapeutics Inc.KPTIAug 12

    Ownership stake disclosure by Adage Capital Management, L.P. (amended)

    Adage Capital Management, L.P., filed by

15. ROUTINESCHEDULE 13G/AKaryopharm Therapeutics Inc.KPTIAug 11

    Ownership stake disclosure by GOLDMAN SACHS GROUP INC (amended)

    GOLDMAN SACHS GROUP INC, filed by

16. ROUTINE8-KKaryopharm Therapeutics Inc.KPTIJul 31

    Current report

17. ROUTINE4Karyopharm Therapeutics Inc.KPTIJul 30

    Stuart Poulton, insider filing for KPTI

    Stuart Poulton, reporting

18. ROUTINESCHEDULE 13GKaryopharm Therapeutics Inc.KPTIJul 28

    Ownership stake disclosure by BlackRock, Inc.

    BlackRock, Inc., filed by

19. ROUTINE8-KKaryopharm Therapeutics Inc.KPTIJul 17

    Current report

20. ROUTINESCHEDULE 13G/AKaryopharm Therapeutics Inc.KPTIJun 5

    Ownership stake disclosure by T. Rowe Price Investment Management, Inc. (amended)

    T. Rowe Price Investment Management, Inc., filed by

21. ROUTINE8-KKaryopharm Therapeutics Inc.KPTIMay 28

    Current report

22. ROUTINES-8Karyopharm Therapeutics Inc.KPTIMay 27

    Employee stock plan registration

23. ROUTINES-8Karyopharm Therapeutics Inc.KPTIMay 27

    Employee stock plan registration

24. ROUTINE4Karyopharm Therapeutics Inc.KPTIMay 26

    6 insider filings

    Christy J. Oliger, insider filing for KPTI

    Show all 6

    • 4Insider filing for KPTIMay 26
    • 4Insider filing for KPTIMay 26
    • 4Insider filing for KPTIMay 26
    • 4Insider filing for KPTIMay 26
    • 4Insider filing for KPTIMay 26
    • 4Insider filing for KPTIMay 26

    Christy J. Oliger, reporting

25. ROUTINESCHEDULE 13GKaryopharm Therapeutics Inc.KPTIMay 15

    Ownership stake disclosure by Ikarian Capital, LLC

    Ikarian Capital, LLC, filed by

26. ROUTINE4Karyopharm Therapeutics Inc.KPTIMay 15

    6 insider filings

    Stuart Poulton, insider filing for KPTI

    Show all 6

    • 4Insider filing for KPTIMay 15
    • 4Insider filing for KPTIMay 15
    • 4Insider filing for KPTIMay 15
    • 4Insider filing for KPTIMay 15
    • 4Insider filing for KPTIMay 15
    • 4Insider filing for KPTIMay 15

    Stuart Poulton, reporting

27. ROUTINESCHEDULE 13GKaryopharm Therapeutics Inc.KPTIMay 15

    Ownership stake disclosure by ACORN BIOVENTURES, L.P.

    ACORN BIOVENTURES, L.P., filed by

28. ROUTINEEFFECTKaryopharm Therapeutics Inc.KPTIMay 15

    Registration declared effective

29. ROUTINEEFFECTKaryopharm Therapeutics Inc.KPTIMay 15

    Registration declared effective

30. ROUTINESCHEDULE 13G/AKaryopharm Therapeutics Inc.KPTIMay 14

    Ownership stake disclosure by Affinity Asset Advisors, LLC (amended)

    Affinity Asset Advisors, LLC, filed by

31. NOTABLE10-QKaryopharm Therapeutics Inc.KPTIMay 14

    Quarterly report

32. ROUTINE8-KKaryopharm Therapeutics Inc.KPTIMay 14

    Current report

33. ROUTINESCHEDULE 13GKaryopharm Therapeutics Inc.KPTIMay 13

    Ownership stake disclosure by Adage Capital Management, L.P.

    Adage Capital Management, L.P., filed by

34. ROUTINESCHEDULE 13GKaryopharm Therapeutics Inc.KPTIMay 12

    Ownership stake disclosure by GOLDMAN SACHS GROUP INC

    GOLDMAN SACHS GROUP INC, filed by

35. ROUTINESCHEDULE 13G/AKaryopharm Therapeutics Inc.KPTIMay 11

    Ownership stake disclosure by Opaleye Management Inc. (amended)

    Opaleye Management Inc., filed by

36. ROUTINES-3Karyopharm Therapeutics Inc.KPTIMay 4

    Securities offering

37. ROUTINES-3Karyopharm Therapeutics Inc.KPTIMay 4

    Securities offering

38. ROUTINE4Karyopharm Therapeutics Inc.KPTIApr 22

    Reshma Rangwala, insider filing for KPTI

    Reshma Rangwala, reporting

39. ROUTINESCHEDULE 13G/AKaryopharm Therapeutics Inc.KPTIApr 13

    Ownership stake disclosure by INTEGRATED CORE STRATEGIES (US) LLC (amended)

    INTEGRATED CORE STRATEGIES (US) LLC, filed by

Older filings on EDGAR